Literature DB >> 27502301

Parkinson Disease and Dementia.

Sara Garcia-Ptacek1, Milica G Kramberger2.   

Abstract

Dementia is a frequent complication of Parkinson disease (PD) with a yearly incidence of around 10% of patients with PD. Lewy body pathology is the most important factor in the development of Parkinson disease dementia (PDD) and there is evidence for a synergistic effect with β-amyloid. The clinical phenotype in PDD extends beyond the dysexecutive syndrome that is often present in early PD and encompasses deficits in recognition memory, attention, and visual perception. Sleep disturbances, hallucinations, neuroleptic sensitivity, and fluctuations are often present. This review provides an update on current knowledge of PDD including aspects of epidemiology, pathology, clinical presentation, management, and prognosis.
© The Author(s) 2016.

Entities:  

Keywords:  Parkinson disease dementia; dementia

Mesh:

Year:  2016        PMID: 27502301     DOI: 10.1177/0891988716654985

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  17 in total

Review 1.  Changes of cerebrospinal fluid Aβ42, t-tau, and p-tau in Parkinson's disease patients with cognitive impairment relative to those with normal cognition: a meta-analysis.

Authors:  Xiaohui Hu; Yan Yang; Daokai Gong
Journal:  Neurol Sci       Date:  2017-08-14       Impact factor: 3.307

2.  Available and future treatments for atypical parkinsonism. A systematic review.

Authors:  Davide Vito Moretti
Journal:  CNS Neurosci Ther       Date:  2018-10-07       Impact factor: 5.243

Review 3.  Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach.

Authors:  Mattia Toni; Maria L Massimino; Agnese De Mario; Elisa Angiulli; Enzo Spisni
Journal:  Front Neurosci       Date:  2017-01-19       Impact factor: 4.677

4.  Assessment of individual cognitive changes after deep brain stimulation surgery in Parkinson's disease using the Neuropsychological Test Battery Vienna short version.

Authors:  Thomas Foki; Daniela Hitzl; Walter Pirker; Klaus Novak; Gisela Pusswald; Eduard Auff; Johann Lehrner
Journal:  Wien Klin Wochenschr       Date:  2017-02-07       Impact factor: 1.704

5.  Apathy and Reduced Speed of Processing Underlie Decline in Verbal Fluency following DBS.

Authors:  Jennifer A Foley; Tom Foltynie; Ludvic Zrinzo; Jonathan A Hyam; Patricia Limousin; Lisa Cipolotti
Journal:  Behav Neurol       Date:  2017-03-20       Impact factor: 3.342

6.  Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?

Authors:  Kurt A Jellinger; Amos D Korczyn
Journal:  BMC Med       Date:  2018-03-06       Impact factor: 8.775

7.  Abnormal Spontaneous Brain Activity in Early Parkinson's Disease With Mild Cognitive Impairment: A Resting-State fMRI Study.

Authors:  Zhijiang Wang; Xiuqin Jia; Huimin Chen; Tao Feng; Huali Wang
Journal:  Front Physiol       Date:  2018-08-14       Impact factor: 4.566

Review 8.  The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders.

Authors:  Anuradha Tarafdar; Giordano Pula
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923

9.  Dementia-Related Functional Disability in Moderate to Advanced Parkinson's Disease: Assessment Using the World Health Organization Disability Assessment Schedule 2.0.

Authors:  Jia-Hung Chen; Chien-Tai Hong; Dean Wu; Wen-Chou Chi; Chia-Feng Yen; Hua-Fang Liao; Lung Chan; Tsan-Hon Liou
Journal:  Int J Environ Res Public Health       Date:  2019-06-24       Impact factor: 3.390

10.  Long non-coding RNA SNHG1 mediates neuronal damage in Parkinson's disease model cells by regulating miR-216a-3p/Bcl-2-associated X protein.

Authors:  Hai Wang; Meng Zhang; Taofeng Wei; Jie Zhou; Yongle Zhang; Dengjun Guo
Journal:  Ann Transl Med       Date:  2021-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.